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Abstract 
Background: Malaria control strategies are focusing on new approaches, such as the symbiotic control, which 
consists in the use of microbial symbionts to prevent parasite development in the mosquito gut and to block the 
transmission of the infection to humans. Several microbes, bacteria and fungi, have been proposed for malaria or 
other mosquito-borne diseases control strategies. Among these, the yeast Wickerhamomyces anomalus has been 
recently isolated from the gut of Anopheles mosquitoes, where it releases a natural antimicrobial toxin. Interestingly, 
many environmental strains of W. anomalus exert a wide anti-bacterial/fungal activity and some of these ‘killer’ yeasts 
are already used in industrial applications as food and feed bio-preservation agents. Since a few studies showed that 
W. anomalus killer strains have antimicrobial effects also against protozoan parasites, the possible anti-plasmodial 
activity of the yeast was investigated.
Methods: A yeast killer toxin (KT), purified through combined chromatographic techniques from a W. anomalus 
strain isolated from the malaria vector Anopheles stephensi, was tested as an effector molecule to target the sporo-
gonic stages of the rodent malaria parasite Plasmodium berghei, in vitro. Giemsa staining was used to detect morpho-
logical damages in zygotes/ookinetes after treatment with the KT. Furthermore, the possible mechanism of action of 
the KT was investigated pre-incubating the protein with castanospermine, an inhibitor of β-glucanase activity.
Results: A strong anti-plasmodial effect was observed when the P. berghei sporogonic stages were treated with 
KT, obtaining an inhibition percentage up to around 90 %. Microscopy analysis revealed several ookinete altera-
tions at morphological and structural level, suggesting the direct implication of the KT-enzymatic activity. Moreover, 
evidences of the reduction of KT activity upon treatment with castanospermine propose a β-glucanase-mediated 
activity.
Conclusion: The results showed the in vitro killing efficacy of a protein produced by a mosquito strain of W. anom-
alus against malaria parasites. Further studies are required to test the KT activity against the sporogonic stages in vivo, 
nevertheless this work opens new perspectives for the possible use of killer strains in innovative strategies to impede 
the development of the malaria parasite in mosquito vectors by the means of microbial symbionts.
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Background
Malaria is one of the most alarming infectious diseases 
threatening millions people, mostly in sub-Saharan 
regions [1, 2]. It is caused by Plasmodium protozoan 
parasites and transmitted by Anopheles mosquitoes. Even 
though several traditional remedies are in use, the disease 
continues to represent a heavy health burden in endemic 
countries. In absence of effective vaccines, public health 
programmes have focused their resources on the use of 
insecticides to reduce the number of vector populations, 
and/or drugs to kill directly the pathogens [3].
Malaria control programmes involving chemical and 
pharmacological treatments are not always sustain-
able due to several factors, such as economic costs and 
logistic aspects. In addition, both vectors and parasites 
have enhanced resistance against many commonly used 
pesticides and medicines. Confirmed resistance of 125 
mosquito species lead the Malaria Eradication Research 
Agenda to state that novel control strategies are urgently 
requested for malaria suppression [4]. In this frame, 
a new tool called “Symbiotic Control” (SC) has been 
recently proposed. The SC is a multifaceted approach 
that exploits symbiotic microorganisms to control insect 
pests reducing their vector capabilities [5, 6]. This strat-
egy implies the identification of suitable microbes able to 
spread among the vector populations. Several microbes 
have been proposed for malaria-SC, including the bacte-
ria Asaia, Wolbachia, Pantoea agglomerans, Elizabethk-
ingia meningoseptica and the fungi Metarhizium robertsii 
and Wickerhamomyces anomalus [7–12].
The yeast W. anomalus has been recently isolated 
from different mosquito species [13] and its intimate 
association with its host has been well characterized in 
the Asian malaria vector Anopheles stephensi, where the 
yeast localizes to gut and gonads, suggesting specific bio-
logical roles in these anatomical districts [12]. Similar to 
various environmental strains used as bio-preservation 
agents for their anti-bacterial/fungal activities in food 
industry, the W. anomalus strain isolated from An. ste-
phensi secretes an antimicrobial KT, which might exert 
an antiseptic function in the mosquito [14, 15]. Previous 
results showed the effective antimicrobial activity of the 
KT, produced by W. anomalus strain of mosquito against 
other targeted yeasts [14]. The W. anomalus potency to 
be stimulated for KT production was demonstrated, 
whose releases in the mosquito midgut and gonads show-
ing long-lasting features [14]. Consequently, the possible 
KT anti-plasmodial effect against parasite developmental 
stages was investigated, taking place in mosquito gut. In 
the present study, a strong in  vitro antimicrobial activ-
ity of the KT secreted by the W. anomalus strain isolated 
from Anopheles stephensi against the sporogonic stages 
of the malaria rodent parasite Plasmodium berghei was 
determined and a killing mechanism of action based on a 
β-glucanase enzymatic activity was proposed.
Methods
Yeast strains
Three W. anomalus strains were used: (1) WaF17.12 
isolated from An. stephensi [12], (2) WaATCC 96603 a 
KT-producer reference strain and (3) WaUM3 a WaKT-
non-producing and, furthermore, WaKT-susceptible 
strain [16, 17]. These yeasts were grown in YPD liquid 
medium (20  g/l peptone, 20  g/l glucose, 10  g/l yeast 
extract) buffered at pH 4.5 with 0.1  M citric acid and 
0.2  M potassium phosphate dibasic and incubated at 
26  °C for 36 h at 70 rpm to stimulate the production of 
KTs [18, 19].
Purification of yeast KTs
The yeast cultures obtained after 36  h incubation were 
centrifuged at 3000 rpm for 10 min to remove cells. The 
supernatants were filtered using 0.22  μm nitrocellulose 
membranes, and concentrated 50×  using an Amicon 
system equipped with Millipore Ultracell ultrafiltration 
disk (MWCO: 10  kDa). The samples were further con-
centrated using Pierce Concentrators centrifugal ultra-
filtration tubes with a MWCO of 9 kDa (Thermo Fisher 
Scientific Inc). Resulting solutions were analysed by 
anion-exchange chromatography on a FPLC AKTA Basic 
device equipped with a HiTrap DEAE FF column (GE 
Healthcare) using a linear gradient of buffer A (0.1 M cit-
ric acid and 0.2 M K2HPO4, pH 4.5) and buffer B (0.1 M 
citric acid and 0.2  M K2HPO4, pH 4.5), flow rate 5  ml/
min.
Retained and non-retained fractions for each strain 
were collected from different runs, quantified for pro-
tein content according to the Bradford’s method [20] and 
tested for the presence of killing activity against the sus-
ceptible strain WaUM3, as described by Cappelli [14]. 
Prior to anti-P. berghei activity assay, the non-retained 
fractions of WaF17.12 and WaATCC 96603 showing the 
KT activity, and the non-retained fraction of WaUM3 
(negative control), were buffer-exchanged with an Hi-
Trap desalting column to PBS 1×  (10  mM Na2HPO4, 
2.7 mM KCl, 138 mM NaCl, pH 7.4) to prevent possible 
interference, like pH-incompatibility, with the parasite 
development.
Ethics statement
BALB/c mice were reared in the animal facilities of the 
University of Camerino (Italy). Experimental animal 
rearing and handling were fully in agreement with the 
Italian Directive 116 of 10/27/92 on the “use and protec-
tion of laboratory animals”, and in compliance with the 
European regulation (86/609) of 11/24/86 (license no. 
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125/94A, issued by the Italian Ministry of Health). The 
experimentation was approved by the Ethical Committee 
of University of Camerino.
Mice infection and Plasmodium berghei sporogonic  
stages cultures
Five-week-old BALB/c mice were infected with a recom-
binant P. berghei strain (PbCTRPp.GFP) from a cryo-
preserved stock, as previously described by Vlachou 
et al. [21]. This transgenic parasite expresses the Green 
Fluorescent Protein (GFP) during ookinete development 
under the control of the ctrp promoter, whereas no sig-
nal is exhibited in the asexual blood stages and gameto-
cytes. After 4  days, mice parasitaemia and haematocrit 
were evaluated using Giemsa staining and Neubauer’s 
chamber, respectively. Mice with a parasitaemia in the 
range 5–10 % were selected as donors, and 107 infected 
red blood cells (IRBC) were inoculated into healthy 
mice, previously treated with phenylhydrazine to induce 
reticulocytosis [22]. After further 4  days, exflagellation 
centres were counted as indicators of parasite infectivity 
[23], using an optical microscope with a 40×  objective 
(Carl Zeiss Axio Observer.Z1, Milan, Italy). To induce 
exflagellation, 5  µl of infected blood were blended 
with 120  µl of incomplete ookinete medium (16.4  g/l 
RPMI1640 containing 25  mM HEPES/l-glutamine, 2  % 
NaHCO3, 0.05  % hypoxanthine, 100  µM xanthurenic 
acid, pH 8) and incubated 20  min at 22  °C as reported 
by Ghosh et  al. [24]. After the check of exflagellation 
centers, gametocytaemic blood was collected by cardiac 
puncture.
Plasmodium berghei sporogonic stages were obtained, 
in  vitro, culturing 20  µl of infected blood with 180  µl 
of complete ookinete medium in a 96-wells microtitre 
plates. Complete medium was prepared supplementing 
the above-mentioned incomplete medium with 20 % heat 
inactivated fetal bovine serum (Invitrogen), 50 U/ml pen-
icillin and 50 µg/ml streptomycin (Invitrogen). Ookinetes 
developed after about 24 h at 19 °C.
In vitro WaKTs anti‑plasmodial activity
The fractions containing the KTs obtained by chro-
matographic analysis of the extracts, from WaF17.12, 
WaATCC 96603 (positive control) and WaUM3 (nega-
tive control) were tested against P. berghei sporogonic 
stage cultures prepared as described above. Four con-
centrations (25, 60, 75, 100  µg/ml) of KTs from both 
WaF17.12 and WaATCC 96603 were tested; whereas for 
WaUM3, the purification product was tested at the high-
est concentration possible to evaluate interference due to 
buffer solution. Concurrently, in each control well, PBS 
1× pH 7.4 (without KT) was added to ookinete complete 
medium and gametocytaemic blood. After 24 h incuba-
tion at 19  °C, the KTs anti-plasmodial activity was esti-
mated comparing the number of fluorescent P. berghei 
sporogonic stages in both control and sample wells using 
a fluorescence microscope and 40× objective (Carl Zeiss 
Axio Observer.Z1, Milan, Italy). The assays were per-
formed in triplicate using 96-wells microtitre plates and 
the results were reported as the averages of inhibition 
percentages of parasite development.
The LC50 (KTs concentration at which 50 % of the par-
asite population is killed) was evaluated after 24 h. This 
value was determined by nonlinear regression analysis 
plotting the number of sporogonic stages versus log[KT] 
with GraphPad Prism 5 software as described by Savoia 
et al. [25].
Statistical analysis
Five runs of parasite cultures were obtained during 
the experimentation and the results of each run were 
reproducible. All the experiments against Plasmodium 
sporogonic stages were repeated in triplicate. The data 
obtained from parasite counts were analysed with Graph-
Pad Prism 5 software and statistical analysis was carried 
out by One Way ANOVA followed by Bonferroni’s Multi-
ple Comparison Tests. Statistical significance is expressed 
as a p value <0.05.
Morphological analysis of Plasmodium berghei sporogonic 
stages using Giemsa staining
Control and KT-treated (KTs concentration 100  μg/ml) 
P. berghei sporogonic stages slides were investigated for 
possible damages induced by KT-activity on the zygote 
and/or ookinete morphologies. Briefly, 5  μl of parasite 
cultures were smeared onto a glass slide, fixed by meth-
anol for 15  min at room temperature and stained for 
45  min with 10  % Giemsa solution (Sigma-Aldrich) in 
PBS 1× pH 7.4. After this incubation period the samples 
were analysed using a microscope and 100×  objective 
(Carl Zeiss Axio Observer.Z1, Milan, Italy).
Castanospermine assay
Purified KTs (100  μg/ml) from both WaF17.12 and 
WaATCC 96603 were pre-incubated with 25  µM of 
castanospermine (Sigma-Aldrich), a β-glucanase inhibi-
tor, for 1  h at 25  °C under static conditions [26] and, 
then, added to the P. berghei cultures, in triplicates. The 
inhibitory effect of the indolizine alkaloid on the antimi-
crobial activity of KTs was evaluated on P. berghei sporo-
gonic stage cultures after 24  h incubation at 19  °C and 
it was indicated as the average of three replicates. Upon 
castanospermine treatment, the number of parasites was 
compared to controls.
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Results
Purification of KTs
The KTs from W. anomalus strains were purified to test 
their ability to inhibit the development of P. berghei 
sporogonic stages. The purification process started with 
the production of the KT in yeast culture medium, and 
proceeded with a series of concentrations and chromato-
graphic steps.
Three different strains of W. anomalus growing in 
conditions stimulating the production of toxin [14] were 
used: (1) the KT-producer WaF17.12 isolated from An. 
stephensi mosquitoes; (2) the KT-producer WaATCC 
96603 (positive control), and (3) the non KT-producer 
WaUM3 (negative control). Anion-exchange chro-
matography analysis has revealed the presence of two 
major peaks in each yeast strains analysed: non-retained 
and retained fractions (Fig. 1). Due to similar chroma-
tographic profiles, a killing activity test was performed 
in order to discriminate effective KT presence in the 
fractions obtained from the three different strains. Kill-
ing activity assay on the susceptible WaUM3 strain, 
revealed KT presence only in the first eluted fraction of 
WaF17.12 and WaATCC 96603 strains (see Additional 
file 1).
Accordingly, these fractions were used against P. 
berghei sporogonic stages.
In vitro anti‑plasmodial activity of WaKTs
KTs purified from WaF17.12 and WaATCC 96603 super-
natants were tested on P. berghei cultures. KT concentra-
tions were compatible with those of killer peptides used 
against the promastigotes of Leishmania sp., in  vitro 
conditions [25]. The KTs secreted by both W. anomalus 
F17.12 and W. anomalus ATCC 96603 showed anti-
plasmodial activity against the development of P. berghei 
sporogonic stages; whereas no effect was detected when 
the cultures were incubated with the purified super-
natant of WaUM3. Indeed, the ookinetes treated with 
non-retained fraction of WaUM3 showed a comparable 
development with the control (see Additional file 2).
Notably, KTs activity showed a dose-depending trend. 
Treatment with 100  µg/ml of WaF17.12 and WaATCC 
96603 KTs induced the highest inhibition percentages 
of the sporogonic stages development (87.5 and 92.3  %, 
respectively) (Fig. 2). Inhibition percentages upon expo-
sure to 25, 60, 75 µg/ml of WaF17.12 KT were approxi-
mately of 17, 43 and 66 %, whereas for WaATCC 96603 
KT were about 16, 48 and 70  % (Fig.  3). The values of 
LC50 were 61.3 and 64.6 µg/ml for WaATCC 96603 and 
WaF17.12, respectively, suggesting an equivalent activity 
of the two proteins.
Investigation of morphological/structural alterations 
in treated parasites
Upon GFP-parasites treatment with KTs, a lower fluo-
rescence signal in the sporogonic stages was detected. 
Figure  4 shows a comparison between control and 
treated parasites from zygotes to ookinetes. Intracellular 
GFP leakage might result from KTs-induced alterations 
on the permeability of the parasites cell membrane. To 
better investigate KT-induced morphological changes 
in P. berghei sporogonic stages, smears of parasites cul-
tures were stained with 10 % Giemsa. Morphologically, 
alterations of the post-zygotic stages were evidenced, 
whereas no particular differences were observed at 
the zygotes level (Fig.  5). In details, zygotes from both 
groups (controls and KTs-treated) appeared comparable 
in size with intensely colored cytoplasm while treated 
ones showed irregular borders and less defined cyto-
plasmic granules and crystalloid precursors (Fig.  5a, 
d). In control parasites, the ookinete development was 
characterized by a completed elongation process and 
the presence of a strong staining and well-defined crys-
talloid organelles surrounded with haemozoin (Fig. 5b, 
c). The morphological/structural alterations of the post-
zygotic stages of the KT-treated parasites included: (1) 
irregular cell-shape and jagged cell borders; (2) a feeble 
staining of cytoplasmic region; (3) the lack of crystal-
loid assembly and (4) less-defined cytoplasmic granules, 
(Fig. 5e, f ).
Fig. 1 Anion-exchange chromatography profile. Profile obtained 
through the anion-exchange chromatography (DEAE) performed on 
the concentrated supernatant of the strain WaF1712. The same elu-
tion profile was achieved also for the strains WaATCC 96603 (positive 
control) and WaUM3 (negative control)
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Possible KT mechanism of action
The main antimicrobial mechanism of W. anomalus 
involves the direct killing of sensitive microorganisms 
by releasing of KTs that recognize specific cell-wall 
receptors on target membranes [27]. One of the pro-
posed mechanism of action of these proteins is based on 
their interference with the glucans determining a β-1,3-
glucanase activity [28].
To verify if the toxicity against the P. berghei sporo-
gonic stages of KTs was mediated by β-glucanase activ-
ity, the KTs of both WaF17.12 and WaATCC 96603 were 
treated with castanospermine, a β-glucanase inhibitor 
[26]. Castanospermine-induced inhibition of KTs was 
evaluated after 24  h incubation compared to controls 
(Table  1). Castanospermine induced a reduction in the 
killer activity of both proteins (from 79.7 to 46.2  % in 
the case of WaF17.12 and from 88.5 to 49.5 % in the case 
of WaATCC 96603) confirming the possible correlation 
between the enzymatic activity of KTs and the killer phe-
notype of the yeast.
Discussion
The yeast W. anomalus is known to display natural anti-
microbial properties against a wide range of microbes, 
including the protozoan parasites Leishmania sp. and 
Acanthamoeba castellanii [15, 25, 29]. Herein, through a 
rapid chromatographic protocol [30], WaKT produced by 
WaF17.12 strain, isolated from the major Asian malaria 
mosquito vector, An. stephensi, was purified. Further-
more, the first evidence of this KT inhibition potential 
against P. berghei sporogonic stages in laboratory cul-
tures was provided. The obtained outcomes report an 
undeniable parasite inhibition up to 90  % compared to 
control samples. Alongside, although WaATCC 96603 
reference strain has been already described for its robust 
Fig. 2 In vitro anti-plasmodial activity of WaKTs against Plasmodium 
berghei sporogonic stages. The development of sporogonic stages 
showed inhibition rates of 87.5 and 92.3 % when they were incubated 
with 100 µg/ml of WaF17.12 and WaATCC 96603 KTs, respectively, 
for 24 h at 19 °C. The histogram reports the average numbers of the 
sporogonic stages obtained from the cell count of three wells for 
each treatment and control (LC50 values were 61.3 and 64.6 µg/ml 
for WaATCC 96603 and WaF17.12, respectively). The One Way ANOVA 
Bonferroni’s Multiple Comparison tests were used to perform the 
statistical analysis. Statistical significance is expressed as a p value. 
***p < 0.001
Fig. 3 Inhibition percentages of Plasmodium berghei sporogonic stages development at different KTs concentration. The KTs of WaF17.12 and 
WaATCC 96603 showed a dose-dependent activity at the tested concentrations of 100, 75, 60 and 25 µg/ml. Inhibition percentages upon exposure 
to 25, 60, 75 µg/ml of WaF17.12 KT were approximately of 17, 43, 66 %, whereas for WaATCC 96603 KT were about 16, 48 and 70 %
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multi-target killing activity, its efficacy against P. berghei 
sporogonic stages was additionally estimated.
Subsequently, WaKT action mechanism was investi-
gated through both enzymatic tests and Giemsa staining. 
Previous work demonstrated that KTs bind to cell-wall 
primary receptors, and then, move to secondary ones 
in the plasma membrane inducing the death of sensitive 
cells through DNA damages and apoptosis [25]. In par-
ticular, KT activity was associated with the hydrolysis of 
the β-glucans located in cell-wall membranes [28]. Nota-
bly, the β-1,3-glucans recognized by KT, are known to be 
present not only in fungi but also in cell-wall of parasites, 
as reported in the protozoa Toxoplasma and Eimeria 
[31], and they are implicated in the immune-protection 
against P. berghei infection in mice [32].
Moreover, it is reported that the bond between the 
KT and the membrane receptors causes the formation 
of transmembrane channels, determining the leak of 
intracellular materials [33]. A similar event was detected 
in amphotericin-treated promastigotes of Leishmania 
major suggesting a loss of intra-cellular material from 
apoptotic cells [25]. In this frame, a lower fluorescent sig-
nal in sporogonic stages treated with KT was observed 
respect to controls. The morphological and structural 
alterations observed in KT-treated parasites, using 
Giemsa staining, confirmed that WaF17.12 KT targets 
Fig. 4 Fluorescence microscopy evaluation of GFP-transfected parasites. Different stages of untreated parasite development are shown in a–c 
(a zygote; b elongated zygote; c mature ookinete). e and g show faint fluorescent signals into zygotes (indicated by white arrows) treated with 
WaF17.12-KT. In d and f phase-contrasts (the zygotes are indicated by white arrows) are shown. All the parasites were observed using a ×100 objec-
tive. In a–c scale bar 10 μm whereas in d–g scale bar 20 μm
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the sporogonic stages of Plasmodium, interfering with 
the correct development of mature ookinetes.
Additionally, β-glucanase implication is also supported 
by the presence of the genes responsible for β-1-3-
glucanase synthesis (EXG1 and EXG2) in the genome of 
W. anomalus [14, 34, 35]: their single or coupled silencing 
was in fact correlated with the lack of the yeast antimi-
crobial function; however, no direct relationship has been 
yet demonstrated between these genes and the KT activ-
ity [36].
For this reason, to evaluate the direct involvement of 
a β-glucanase activity of KT on malaria parasites, the 
β-glucanase inhibitor castanospermine was used. The 
inhibitory effect of castanospermine on the WaKT activ-
ity confirmed a β-glucanase-mediated mechanism of 
action, resulting consistent with data on Tetrapisispora 
phaffi [26]. However it is worth to underline that inhibi-
tion percentages in castanospermine-treated samples is 
still lower with respect untreated control: this is easily 
explained by the shortage of a suitable molecule concen-
tration to saturate all the KT active sites.
Finally, an in-depth analysis of our results rein-
forced the idea that KT, produced by the strain isolated 
from mosquitoes, interacts with specific receptors, the 
β-glucans, localized on the surface of P. berghei cells and 
strongly inhibits their development from gametocytes to 
ookinetes.
Conclusion
The overall outcome from this study paves the way 
for better understanding of the effect of WaKTs on the 
malaria parasite in the mosquito midgut, which coincides 
with the bottleneck in Plasmodium life cycle. Previously, 
Cappelli et al. showed that the W. anomalus strain asso-
ciated to mosquito is able to produce a KT in An. ste-
phensi [14]. Herein, it was demonstrated that this protein 
Fig. 5 Images of Plasmodium berghei cultures in Giemsa-stained smears. Parasites sporogonic stages, both controls (a–c) and treated with 100 µg/
ml of WaF17.12 KT (d–f) were stained with Giemsa and analysed under light microscope (×100 objective). See text for details. Scale bar 10 μm
Table 1 Effects of castanospermine on KTs activity against P. berghei
Pretreatment Treatment Average number of  
sporogonic stages/wellβ‑Glucanase inhibitor (25 μM) KTs (100 μg/ml)
None None 305 ± 22.7
None WaF17.12-KT 62 ± 11.5
None WaATCC 96603-KT 35 ± 4.6
Castanospermine WaF17.12-KT 125 ± 8.1
Castanospermine WaATCC 96603-KT 151 ± 4.5
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is strongly active against P. berghei, in  vitro conditions. 
Future in  vivo studies will focus on the action of KTs 
against rodent malaria parasites with the prospect to pro-
vide a natural tool for innovative malaria SC strategies.
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